SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation

Molecular and Cellular Biology

Volumn 31, Issue 8, 2011, Pages 1594-1609

  Kapoor Vazirani, Priya ^a   Kagey, Jacob D ^a   Vertino, Paula M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE H4; HISTONE H4K16; HISTONE H4K20; NEGATIVE ELONGATION FACTOR; PROTEIN; PROTEIN BRD4; PROTEIN HMOF; PROTEIN SUV420H2; PROTEIN TMS1; RNA POLYMERASE II; TRANSCRIPTION ELONGATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME RELEASE; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENE SILENCING; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; RNA TRANSLATION; TRANSCRIPTION INITIATION; UPREGULATION;

ACETYLATION; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; METHYLATION; PROMOTER REGIONS, GENETIC; RNA POLYMERASE II;

EID: 79953131815     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00524-10     Document Type: Article

References (69)

1. Adelman, K., et al. 2005. Efficient release from promoter-proximal stall sites requires transcript cleavage factor TFIIS. Mol. Cell 17:103-112.
2. Benetti, R., M. Garcia-Cao, and M. A. Blasco. 2007. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39:243-250.
3. Benetti, R., et al. 2007. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 178:925-936.
4. Bird, A. P. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
5. Cai, Y., et al. 2010. Subunit composition and substrate specificity of a MOFcontaining histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J. Biol. Chem. 285:4268-4272.
6. Chekhun, V. F., N. Y. Lukyanova, O. Kovalchuk, V. P. Tryndyak, and I. P. Pogribny. 2007. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol. Cancer Ther. 6:1089-1098.
7. Cheng, B., and D. H. Price. 2007. Properties of RNA polymerase II elongation complexes before and after the P-TEFb-mediated transition into productive elongation. J. Biol. Chem. 282:21901-21912.
8. Collard, R. L., N. S. Harya, F. A. Monzon, C. E. Maier, and D. S. O'Keefe. 2006. Methylation of the ASC gene promoter is associated with aggressive prostate cancer. Prostate 66:687-695.
9. Congdon, L. M., S. I. Houston, C. S. Veerappan, T. M. Spektor, and J. C. Rice. 2010. PR-Set7-mediated monomethylation of histone H4 lysine 20 at specific genomic regions induces transcriptional repression. J. Cell. Biochem. 110:609-619.
10. Conway, K. E., et al. 2000. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res. 60:6236-6242.
11. Core, L. J., J. J. Waterfall, and J. T. Lis. 2008. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322:1845-1848.
12. Crawford, N. P., et al. 2008. Bromodomain 4 activation predicts breast cancer survival. Proc. Natl. Acad. Sci. U. S. A. 105:6380-6385.
13. Dey, A., F. Chitsaz, A. Abbasi, T. Misteli, and K. Ozato. 2003. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. U. S. A. 100:8758-8763.
14. Dou, Y., et al. 2005. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121:873-885.
15. Egger, G., A. M. Aparicio, S. G. Escobar, and P. A. Jones. 2007. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment. Cancer Res. 67:346-353.
16. Fraga, M. F., et al. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37:391-400.
17. French, C. A., et al. 2001. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am. J. Pathol. 159:1987-1992.
18. Gilchrist, D. A., et al. 2008. NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly. Genes Dev. 22:1921-1933.
19. Gilmour, D. S. 2009. Promoter proximal pausing on genes in metazoans. Chromosoma 118:1-10.
20. Gonzalo, S., et al. 2005. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol. 7:420-428.
21. Graff, J. R., J. G. Herman, S. Myohanen, S. B. Baylin, and P. M. Vertino. 1997. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272:22322-22329.
22. Guenther, M. G., S. S. Levine, L. A. Boyer, R. Jaenisch, and R. A. Young. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:77-88.
23. Issa, J. P. 2007. DNA methylation as a therapeutic target in cancer. Clin. Cancer Res. 13:1634-1637.
24. Jacinto, F. V., E. Ballestar, and M. Esteller. 2009. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation. Oncogene 28:4212-4224.
25. Jang, M. K., et al. 2005. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19:523-534.
26. Jia, D., R. Z. Jurkowska, X. Zhang, A. Jeltsch, and X. Cheng. 2007. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449:248-251.
27. Jones, P. A., and D. Takai. 2001. The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070.
28. Kagey, J. D., P. Kapoor-Vazirani, M. T. McCabe, D. R. Powell, and P. M. Vertino. 2010. Long-term stability of demethylation after transient exposure to 5-aza-2'-deoxycytidine correlates with sustained RNA polymerase II occupancy. Mol. Cancer Res. 8:1048-1059.
29. Kapoor-Vazirani, P., J. D. Kagey, D. R. Powell, and P. M. Vertino. 2008. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity. Cancer Res. 68:6810-6821.
30. Kim, D., B. J. Blus, V. Chandra, P. Huang, F. Rastinejad, and S. Khorasanizadeh. 2010. Corecognition of DNA and a methylated histone tail by the MSL3 chromodomain. Nat. Struct. Mol. Biol. 17:1027-1029.
31. Levine, J. J., K. M. Stimson-Crider, and P. M. Vertino. 2003. Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 22:3475-3488.
32. Li, X., L. Wu, C. A. Corsa, S. Kunkel, and Y. Dou. 2009. Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol. Cell 36:290-301.
33. Marshall, N. F., and D. H. Price. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:12335-12338.
34. Masumoto, J., et al. 1999. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274:33835-33838.
35. Matsui, T., et al. 2010. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464:927-931.
36. McCabe, M. T., J. C. Brandes, and P. M. Vertino. 2009. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin. Cancer Res. 15:3927-3937.
37. McConnell, B. B., and P. M. Vertino. 2004. TMS1/ASC: the cancer connection. Apoptosis 9:5-18.
38. McGarvey, K. M., et al. 2006. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66:3541-3549.
39. Mendjan, S., et al. 2006. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol. Cell 21:811-823.
40. Moore, S. A., Y. Ferhatoglu, Y. Jia, R. A. Al-Jiab, and M. J. Scott. 2010. Structural and biochemical studies on the chromo-barrel domain of male specific lethal 3 (MSL3) reveal a binding preference for mono or dimethyl lysine 20 on histone H4. J. Biol. Chem. 285:40879-40890.
41. Muse, G. W., et al. 2007. RNA polymerase is poised for activation across the genome. Nat. Genet. 39:1507-1511.
42. Nechaev, S., and K. Adelman. 2008. Promoter-proximal Pol II: when stalling speeds things up. Cell Cycle 7:1539-1544.
43. Nishioka, K., et al. 2002. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 9:1201-1213.
44. Ottaviano, Y. L., et al. 1994. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54:2552-2555.
45. Parsons, M. J., P. Patel, D. J. Brat, L. Colbert, and P. M. Vertino. 2009. Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells. Cancer Res. 69:1706-1711.
46. Parsons, M. J., and P. M. Vertino. 2006. Dual role of TMS1/ASC in death receptor signaling. Oncogene 25:6948-6958.
47. Pesavento, J. J., H. Yang, N. L. Kelleher, and C. A. Mizzen. 2008. Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle. Mol. Cell. Biol. 28:468-486.
48. Pfister, S., et al. 2008. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int. J. Cancer 122:1207-1213.
49. Pogribny, I. P., et al. 2006. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 27:1180-1186.
50. Schotta, G., et al. 2004. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18:1251-1262.
51. Schotta, G., et al. 2008. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 22:2048-2061.
52. Smith, E. R., et al. 2005. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol. Cell. Biol. 25:9175-9188.
53. Stimson, K. M., and P. M. Vertino. 2002. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG islandlocalized changes in chromatin architecture. J. Biol. Chem. 277:4951-4958.
54. Stone, A. R., et al. 2004. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am. J. Pathol. 165:1151-1161.
55. Sun, J., and R. Li. 2010. Human negative elongation factor activates transcription and regulates alternative transcription initiation. J. Biol. Chem. 285:6443-6452.
56. Taipale, M., et al. 2005. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol. Cell. Biol. 25: 6798-6810.
57. Takeshima, H., S. Yamashita, T. Shimazu, T. Niwa, and T. Ushijima. 2009. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res. 19:1974-1982.
58. Thomas, M. C., and C. M. Chiang. 2006. The general transcription machinery and general cofactors. Crit. Rev. Biochem. Mol. Biol. 41:105-178.
59. Van Den Broeck, A., et al. 2008. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin. Cancer Res. 14:7237-7245.
60. Venters, B. J., and B. F. Pugh. 2007. Chromatin meets RNA polymerase II. Genome Biol. 8:319.
61. Wada, T., T. Takagi, Y. Yamaguchi, D. Watanabe, and H. Handa. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17:7395-7403.
62. Wang, Z., et al. 2009. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138:1019-1031.
63. Wu, C. H., et al. 2003. NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev. 17:1402-1414.
64. Yamada, T., et al. 2006. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol. Cell 21:227-237.
65. Yamaguchi, Y., et al. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
66. Yang, H., and C. A. Mizzen. 2009. The multiple facets of histone H4-lysine 20 methylation. Biochem. Cell Biol. 87:151-161.
67. Yang, H., et al. 2008. Preferential dimethylation of histone H4 lysine 20 by Suv4-20. J. Biol. Chem. 283:12085-12092.
68. Zeitlinger, J., et al. 2007. Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests integration of diverse patterning processes in the Drosophila embryo. Genes Dev. 21:385-390.
69. Zippo, A., et al. 2009. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138: 1122-1136.